NCT06762379View on ClinicalTrials.gov

Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration

RecruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2030

Conditions
Metastatic Prostate Cancer (mPC)
Trial Locations (1)

20141

RECRUITING

European Institute of oncology, Milan

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

European Institute of Oncology

OTHER